Oxford Immune Algorithmics (OIA) has transitioned its main branding and public face to Algocyte, which is the name of its flagship AI-powered remote health monitoring platform.

Algocyte® is a Physical AI-driven, end-to-end healthcare solution developed by Oxford Immune Algorithmics® (OIA), a deep-tech company incubated by Oxford University, developed in the Cambridge ecosystem and spun out from King's College London. Algocyte's ultraportable physics-informed AI medical instrument for blood testing and data-collecting platform combine subjective, contextual and objective medical data for differential diagnosis. It exploits safer and causally-grounded AI to track each individual immune system to enable precision healthcare and predictive medicine, transforming current reactive sick care to proactive real health care.

Algocyte Board

• Hector Zenil - Founder and Chief Visionary Officer

• Pamela Winsor

• Allan Bezanson

• Jesper N. Tegnér

Algocyte Leadership

• Michelle Lea

• Kourosh Saeb-Parsy